Reducing alcohol use and improving HIV care for men with pregnant partners

Utilizing Implementation Research Methodologies to Adapt an Intervention to Reduce Alcohol Use and Improve HIV Care Outcomes among Men Living with HIV who have Serodiscordant Pregnant Partners

['FUNDING_CAREER'] · SAN DIEGO STATE UNIVERSITY · NIH-10924628

This study is testing a program called Kisoboka to help men with HIV in Uganda who have pregnant partners that are HIV-negative, by encouraging them to cut down on drinking alcohol so they can stick to their HIV treatment and keep their partners safe during pregnancy.

Quick facts

Phase['FUNDING_CAREER']
Study typeNih_funding
SexAll
SponsorSAN DIEGO STATE UNIVERSITY (nih funded)
Locations1 site (SAN DIEGO, UNITED STATES)
Trial IDNIH-10924628 on ClinicalTrials.gov

What this research studies

This research aims to adapt an intervention called Kisoboka to help men living with HIV in Uganda who have pregnant partners that are HIV-negative. The focus is on reducing hazardous alcohol use, which can lead to poor adherence to HIV treatment and increase the risk of HIV transmission. By using motivational interviewing and behavioral economics, the intervention seeks to improve health outcomes for these men and their partners. The goal is to create a supportive environment that encourages adherence to antiretroviral therapy and reduces the risk of HIV during pregnancy.

Who could benefit from this research

Good fit: Ideal candidates for this research are men living with HIV in Uganda who have pregnant partners and engage in hazardous alcohol use.

Not a fit: Patients who are not living with HIV or do not have pregnant partners may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly improve health outcomes for men living with HIV and their pregnant partners by reducing alcohol use and enhancing adherence to HIV treatment.

How similar studies have performed: Previous research has shown that interventions targeting alcohol use and HIV adherence can be effective, suggesting that this approach has the potential for success.

Where this research is happening

SAN DIEGO, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.